Daniel Parera News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Daniel parera. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Daniel Parera Today - Breaking & Trending Today

Samsung Biologics to offer solutions for Kurma Partners' portfolio firms

Samsung Biologics said Tuesday it inked a partnership with Kurma Partners, a French venture capital firm specializing in financing health care companies, to offer a variety of drug-related services to Kurma Partners' portfolio companies. Under the partnership, Samsung Biologics will provide biotech companies invested in by Kurma Partners with its customizable chemical, manufacturing and control solutions. Custom. ....

Samsung Biologics , Daniel Parera , Kurma Partners , Kurma Partner , Samsung Biologic , The Korea Herald , Orean News , Outh Korea News , Outh Korea News In English , Sia News , K Pop , 코리아 헤럴드 ,

Shorla Oncology Secures $35M Series B Funding Round to Advance its Oncology Product Portfolio

CAMBRIDGE, Mass., October 04, 2023 Shorla Oncology (‘Shorla’), a U.S.-Ireland specialty pharmaceutical company, today announced that it has raised $35 million in Series B funding, led by Kurma Partners’ Growth Opportunities Fund, with participation from existing investors Seroba Life Sciences and Irish, U.S. and Canadian based family offices and Enterprise Ireland. The funding will enable Shorla to accelerate the growth of its oncology portfolio by advancing its pipeline, bringing therapies to ....

United Kingdom , Kurma Biofund , Sharon Cunningham , Daniel Parera , Orlaith Ryan , Us Department Of Health , Seroba Life Sciences , Kurma Partner Growth Opportunities Fund , Growth Opportunities Fund , Human Services , Eurazeo Group , Shorla Oncology , Nelarabine Injection , Specialty Pharma , European Healthcare , Life Science , Regulatory Overview , Systematic Review , European Venture Capital , Kurma Partners , Seriesb Funding , Urma Partners Growth Opportunities Fund , Sharon Cunningham , Kurma Partners , Enterprise Ireland , Pharmaceutical Company ,